XML 56 R46.htm IDEA: XBRL DOCUMENT v3.5.0.2
Equity-Based Compensation - Additional Information (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2016
USD ($)
Sep. 30, 2016
USD ($)
$ / shares
shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Equity-based compensation expense $ 2,493,000 $ 4,119,000
Weighted- Average Exercise Price Per Share, Granted | $ / shares   $ 1.18
Class D Common Units    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Equity-based compensation expense   $ 1,353,000
Class D Common Units | Fulgent Therapeutics LLC    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Cancellation of common stock ratio   0.1316
2015 Equity Incentive Plan    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Stock option vesting period   4 years
Stock option expiration period   10 years
Equity-based compensation expense   $ 0
2015 Equity Incentive Plan | Options    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Equity-based compensation expense   $ 1,113,000
2016 Omnibus Incentive Plan | Class D Common Units | Options    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Cancellation of common stock ratio   0.1316
2016 Omnibus Incentive Plan | Employees Directors and Consultants | Maximum    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Shares available for issuance under the plan | shares   2,038,000
Restricted Stock Units (RSUs)    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Equity-based compensation expense   $ 27,000
Expected to be recognized, weighted-average period   3 years 10 months 24 days
Total compensation cost not yet recognized on grant date 770,000 $ 770,000
Compensation cost not yet recognized on grant date, period for recognition   4 years
Unrecognized compensation expense 743,000 $ 743,000
Restricted Stock Units (RSUs) | 2015 Equity Incentive Plan    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Stock option vesting period   4 years
Restricted Stock Units (RSUs) | 2016 Omnibus Incentive Plan | Class D Common Units | Fulgent Therapeutics LLC    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Cancellation of common stock ratio   0.1316
Option Awards    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Weighted- Average Exercise Price Per Share, Granted | $ / shares   $ 6.98
Unrecognized compensation expense $ 2,000,000 $ 2,000,000
Expected to be recognized, weighted-average period   3 years 1 month 6 days
Share and Restricted Stock Unit Awards    
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]    
Equity-based compensation expense   $ 1,600,000